Emerging from the UK, retatrutide, a innovative compound , is creating considerable interest within the scientific community regarding its potential for weight regulation. This dual GIP and GLP-1 receptor agonist looks to deliver a considerable advantage over current therapies, showing promising results in early clinical trials . Researchers sugges